Intra-articular biomaterials-assisted delivery to treat temporomandibular joint disorders
- PMID: 29785258
- PMCID: PMC5954570
- DOI: 10.1177/2041731418776514
Intra-articular biomaterials-assisted delivery to treat temporomandibular joint disorders
Abstract
The temporomandibular joint disorder, also known as myofascial pain syndrome, is considered one of the prevalent chronic pain diseases caused by muscle inflammation and cartilage degradation in head and neck, and thus influences even biopsychosocial conditions in a lifetime. There are several current treatment methodologies relieving inflammation and preventing degradation of the joint complex. One of the promising non-surgical treatment methods is an intra-articular injection of drugs such as corticosteroids, analgesics, and anti-depressants. However, the side effects of drugs due to frequent injections and over-doses, including dizziness, dry mouth, and possible drug dependency are considered limitations. Thus, the delivery of therapeutic molecules through the use of nano/microparticles is currently considered as a promising strategy primarily due to the controlled release. This review highlights the nano/microparticle systems for effective intra-articular therapeutics delivery to prevent cartilage degradation and protect subchondral bone in a temporomandibular joint.
Keywords: Temporomandibular joint; intra-articular injection; myofascial pain syndrome; nano/microparticles; temporomandibular joint disorder; therapeutics delivery.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Stoustrup P, Kristensen KD, Verna C, et al. Intra-articular steroid injection for temporomandibular joint arthritis in juvenile idiopathic arthritis: a systematic review on efficacy and safety. Semin Arthritis Rheum 2013; 43: 63–70. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
